Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area stem cell stem gsk 3'

Search results for: 'research area stem cell stem gsk 3'

Items 111-120 of 151

Page
per page
  1. PF-543 Citrate
    A3718 PF-543 Citrate
    Summary: SphK1 inhibitor,potent and cell-permeate
      ≥89.4 mg/mL
  2. CK 869
    B5788 CK 869
    Summary: actin-related protein 2/3 (Arp2/3) complex inhibitor
      Soluble in DMSO
  3. 2,3-Diaminopropionic acid hydrochloride
    C6585 2,3-Diaminopropionic acid hydrochloride
      Insoluble in DMSO; insoluble in EtOH; ≥27.4 mg/mL
  4. 2,3,4-Trihydroxybenzoic acid
    C7143 2,3,4-Trihydroxybenzoic acid
      ≥29.6 mg/mL
  5. PTIQ
    B7688 PTIQ
    Summary: MMP-3 expression inhibitor
      insoluble in 1eq. NaOH; <23.53 mg/mL
  6. SC 144
    A2173 SC 144
     1 Citation
    Target: Glycoproteins
    Summary: Gp130 inhibitor
      insoluble in EtOH; insoluble in H2O; ≥16.1 mg/mL
  7. NGR peptide
    B1434 NGR peptide
    Summary: Cell-penetrating peptide
      insoluble in EtOH; ≥20.3 mg/mL
  8. BAMB-4
    B4715 BAMB-4
    Summary: Inositol-1,4,5-trisphosphate-3-kinase A (ITPKA) inhibitor
      insoluble in H2O; insoluble in EtOH; ≥7.8 mg/mL
  9. egg white lysozyme (19-36) [Gallus gallus]
    A1065 egg white lysozyme (19-36) [Gallus gallus]
    Summary: Dissolution of cell wall
      insoluble in H2O; insoluble in EtOH; ≥402.3 mg/mL
  10. Artesunate
    B3662 Artesunate
    Summary: derivative of the natural product artemisinin
      insoluble in H2O; ≥16.3 mg/mL

Items 111-120 of 151

Page
per page
Shop By
Now Shopping by
  1. Category Others Remove This Item
Clear All
Shopping Options
Category
  1. Actin 4item
  2. Adenylate cyclase 1 item
  3. AhR 7item
  4. Antioxidants 3item
  5. BCRP 1 item
  6. CaM kinase II 3item
  7. Cell Adhesion Molecules 1 item
  8. Cell Penetrating Peptide 1 item
  9. Cytokine 2item
  10. Enzyme Substrates / Activators 1 item
  11. ES-FLI1/RHA 1 item
  12. FLAP 1 item
  13. Fluorescent Probes 2item
  14. FXR 1 item
  15. GLI 1 item
  16. Glycoprotein 2item
  17. Glycosylases 1 item
  18. Guanylate Cyclase 1 item
  19. Hexokinase 1 item
  20. Hydroxylases 3item
  21. iNOS 1 item
  22. Inositol Phosphatases 1 item
  23. LXR 2item
  24. Matrix Metalloprotease 1 item
  25. MDR multidrug resistance 1 item
  26. Menin-MLL 1 item
  27. Miscellaneous Compounds 1 item
  28. Myosin 3item
  29. NAE 1 item
  30. NADPH Oxidase 1 item
  31. Nampt 1 item
  32. Natriuretic Peptide Receptors 2item
  33. nNOS 2item
  34. Nuclear Receptors 2item
  35. Oxygenases/Oxidases 1 item
  36. PGC-1α 1 item
  37. RARs 4item
  38. Reagents 7item
  39. Reductases 3item
  40. SGK 2item
  41. SPHK 1 item
  42. Synthases/Synthetases 2item
  43. Thrombopoietin Receptor 1 item
  44. Transcription Factors 3item
  45. β(1,3)-D-Glucan Synthase 1 item
  46. Others 51item
  47. BMI-1 1 item
  48. SOD 1 item
  49. Homodimerizers 1 item
  50. Protein synthesis 1 item
Specificity
  1. Selective 24item
Reversibility
  1. Irreversible 2item
Target
  1. Glycoproteins 1 item
  2. P-glycoprotein (P-gp) 1 item
  3. SGK 2item
  4. Liver X receptors (LXRs) 1 item
  5. Microtubules/Tubulins 1 item
  6. BMI-1 1 item
  7. Ca2 /calmodulin-dependent protein kinases (CaMKs) 3item
  8. BCPCF efflux 1 item
  9. P2X Receptors 1 item
  10. TAK1 1 item
  11. RAR/RXR 1 item
  12. DYRK 1 item
  13. Aldosterone receptor 1 item
  14. NAE 1 item
  15. Ubiquitin-activating Enzyme E1 1 item
  16. SUMOylation 1 item
  17. ATGL 1 item
  18. Menin-MLL 1 item
  19. quinone oxidoreductase 1 item
  20. Rev-Erb Receptors 1 item
  21. Aryl hydrocarbon receptors (AHRs) 1 item
  22. RHA 1 item
  23. FKBP 1 item
  24. FXR 1 item
Reported Experiments
  1. Animal Experiments 23item
  2. Cell Experiments 23item
Related Disease
  1. Breast Cancer 1 item
  2. Cancer 8item
  3. Colon Cancer 2item
  4. Colorectal Cancer 2item
  5. Dyslipidemia 1 item
  6. HIV 1 item
  7. Inflammatory Diseases 2item
  8. Leukemia 2item
  9. Lung Cancer 1 item
  10. Lymphoma 1 item
  11. Melanoma 1 item
  12. Non-small Cell Lung Cancer 1 item
  13. Ovarian Cancer 1 item
  14. Prostate Cancer 1 item